Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
D015068:17-Ketosteroids / Q000652:urine; D001772:Blood Cell Count; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects / Q000627:therapeutic use*; D008656:Mestranol / Q000009:adverse effects / Q000627:therapeutic use*; D010060:Ovulation; D011276:Pregnanediol / Q000652:urine
D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D006065:Gonadotropins, Pituitary; D008656:Mestranol; D011276:Pregnanediol; D008234:Lynestrenol